The clinical pharmacist's performance against the COVID-19 pandemic
DOI:
https://doi.org/10.33448/rsd-v10i12.20287Keywords:
Clinical Pharmacist; Medicines; Pandemic; COVID-19.Abstract
Nowadays, the pharmacist plays a very important role, taking actions aimed at the rational use of medicines, with the pandemic, he manages the hospital pharmacy aimed at combating COVID-19 and in community pharmacies providing pharmaceutical care. The study aims to describe the professional's performance during the pandemic. The present study is an integrative review, based on bibliographic research established through articles published on the role of clinical pharmacists in the face of COVID-19. Data collection was carried out between February and March 2021, where studies published in the following databases were investigated: Science Direct, PubMed and MEDLINE through Capes Periodicals. The role of the pharmacist in combating the coronavirus has been fundamental in guiding patients with comorbidities who seek information about drugs in the pathological process of COVID-19, supply and control of stocks of medical and hospital materials, in clinical care activities, dealing with their use safe and rational medications, preventing errors related to medications and taking care of the stability of drugs, whether after dilution or reconstitution, was fundamental for the economy and the use of scarce resources. As we are going through difficult times, the pharmacist is acting in the face of this pandemic, becoming an essential professional, since he has full support to integrate the health teams at the front, developing all his expertise regarding medicines, doses, adverse effects and drug interactions, supporting other professionals and guiding patients with pharmaceutical care.
References
Araujo, L. F. S., Strina, A., Grassi, M. F. R. G. & Teixeira, M. G. (2020). Aspectos clínicos e terapêuticos da infecção da COVID-19. ARCAR FIOCRUZ, 2020. https://www.arca.fiocruz.br/bitstream/icict/40662/2/Aspectos-cl%c3%adnicos-e-terap%c3%aauticos-da-infec%c3%a7%c3%a3o-da-COVID-19-1.pdf.
Bousquat, A., Giovanella, L., Medina, M. G., Mendonça, M. H. M., Facchini, L. A. & Tasca, R. (2020). Desafios da Atenção Básica no enfrentamento da pandemia da Covid-19 no SUS. Relatório de Pesquisa. USP, Fiocruz, UFBA, UFPEL, OPAS Brasil. Rede de Pesquisa em Atenção Primária à Saúde da Abrasco. Rio de Janeiro: Rede de Pesquisa em APS Abrasco. https://redeaps.org.br/wp-content/uploads/2020/11/Relat%C3%B3rioEstadual_RJ_24.10.2020-1.pdf.“.
Cadogan, C. A. & Hughes, C. M. (2021). On the frontline against COVID-19: Community pharmacists’ contribution during a public health crisis. Research in Social and Administrative Pharmacy, 17(1), 2032-5. https://www.sciencedirect.com/science/article/abs/pii/S1551741120302928.“.
Correr, C. (2019). Farmácia, Serviços Farmacêuticos: 7 tipos que podem ajudar sua farmácia, Curitiba, v. 1, n. 1, p.1-5. https://clinicarx.com.br/blog/7-tipos-de-servicos-farmaceuticos-que-podem-ajudar-sua-farmacia/.
da Silva, A. A. (2018). No sinuoso trilho do empreendedorismo. Análise Social, 53(229 (4), 984-1009. http://analisesocial.ics.ul.pt/documentos/n229_a06.pdf.
de Albuquerque, N. L. S. (2020). Planejamento operacional durante a pandemia de COVID-19: comparação entre recomendações da Organização Mundial da Saúde e o plano de contingência nacional. Cogitare Enfermagem, 25. http://revista.farmacoterapia.pt/index.php/rpf/article/view/279.
de Farmácia, C. F. (2020). Guia para estratificação de risco de suspeitos de Covid-19 e delineamento de cuidado farmacêutico para farmácias comunitárias. Brasília: Conselho Federal de Farmácia. http://covid19.cff.org.br/wp-content/uploads/2020/05/delineamento_versao4.pdf.
Ferreira, E. A., Alves, D. C. S. Q., Parnaíba, F. J. B., da Silva, N. D., Barreto, S. C., Rodrigues, A. C. S., ... & Marcelino, S. A. (2019). Fatores Associados a não Adesão ao Tratamento da Hipertensão Arterial Sistêmica em Clientes Idosos/Factors Associated with Non-Adherence to the Treatment of Systemic Arterial Hypertension in Elderly. ID on line REVISTA DE PSICOLOGIA, 13(44), 865-876. https://doi.org/10.14295/idonline.v13i44.1660.
Kretchy, I. A., Asiedu-Danso, M., & Kretchy, J. P. (2021). Medication management and adherence during the COVID-19 pandemic: perspectives and experiences from low-and middle-income countries. Research in social and administrative pharmacy, 17(1), 2023-2026. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7158799/.
Le, T.; Toscani, M.; Colaizzi, J. (2020). Telefarmácia: um novo paradigma para nossa profissão. Journal of Pharmacy Practice, 33(2), 176-182. https://pubmed.ncbi.nlm.nih.gov/30060679/.
Liu, S., Luo, P., Tang, M., Hu, Q., Polidoro, J. P., Sun, S., & Gong, Z. (2020). Providing pharmacy services during the coronavirus pandemic. International journal of clinical pharmacy, 42(2), 299-304. https://onlinelibrary.wiley.com/doi/full/10.1111/ijcp.13890.
Lythgoe, M. P., & Middleton, P. (2020). Ongoing clinical trials for the management of the COVID-19 pandemic. Trends in pharmacological sciences, 41(6), 363-382. https://www.sciencedirect.com/science/article/abs/pii/S0165614720300705.
McKee, D. L., Sternberg, A., Stange, U., Laufer, S., & Naujokat, C. (2020). Candidate drugs against SARS-CoV-2 and COVID-19. Pharmacological research, 157, 104859. https://doi.org/10.1016/j.phrs.2020.104859.
Mehra, M. R., Desai, S. S., Ruschitzka, F., & Patel, A. N. (2020). RETRACTED: Hydroxychloroquine or chloroquine with or without a macrolide for treatment of COVID-19: a multinational registry analysis. 2020. https://doi.org/10.1016/S0140-6736(20)31180-6.
Mendonça, R. O. L.; Rossoni, H. A. V. (2019). Logística Reversa de Medicamentos: Oportunidades para o farmacêutico, benefício para o meio ambiente. Cartilha Reserva de medicamentos - CRFMG. https://www.crfmg.org.br/site/uploads/areaTecnica/20200117[150411]Cartilha_de_ Logistica_Reversa_de_Medicamentos.pdf.
Oliveira, N. V. B. V. D., Szabo, I., Bastos, L. L., & Paiva, S. P. (2017). Atuação profissional dos farmacêuticos no Brasil: perfil sociodemográfico e dinâmica de trabalho em farmácias e drogarias privadas. Saúde e Sociedade, 26, 1105-1121. http://dx.doi.org/10.1590/s0104-12902017000002.
Resende, L. C. (2016). Implantação do serviço de acompanhamento farmacoterapêutico em unidade de atenção primária à saúde de Betim: experiência do Projeto Dia a Dia. Experiências Exitosas de Farmacêuticos no SUS, 4(4), 40-48. http://revistas.cff.org.br/?journal= experienciasexitosas&page=article&op=view&path%5B%5D=1462.
Rossignol, J. F. (2016). Nitazoxanide, a new drug candidate for the treatment of Middle East respiratory syndrome coronavirus. Journal of infection and public health, 9(3), 227-230. https://doi.org/10.1016/j.jiph.2016.04.001.
Rossignoli, P., Pontarolli, D. R. S., Moretoni, C. B., Limberger, P. M., & Nunes, M. (2020). Enfrentamento da Covid-19 nas unidades de assistência farmacêutica na Secretaria de Saúde do Paraná. Revista de Saúde Pública do Paraná, 3(Supl.). http://www.saude.pr.gov.br.
Silveira, M. C. D. (2019). O uso Off Label de Medicamentos no Brasil (Doctoral dissertation). https://www.arca.fiocruz.br/handle/icict/39683.
Song, Z., Hu, Y., Zheng, S., Yang, L., & Zhao, R. (2021). Hospital pharmacists’ pharmaceutical care for hospitalized patients with COVID-19: Recommendations and guidance from clinical experience. Research in Social and Administrative Pharmacy, 17(1), 2027-2031. https://pubmed.ncbi.nlm.nih.gov/32273253/.
Tay, M. Z., Poh, C. M., Rénia, L., MacAry, P. A., & Ng, L. F. (2020). The trinity of COVID-19: immunity, inflammation and intervention. Nature Reviews Immunology, 20(6), 363-374. https://www.nature.com/articles/s41577-020-0311-8.
Torres, P. L., Messias, M., do Nascimento, S. S., Tsoulfas, V. T. M., Rezende, E., & de Aguiar, V. L. (2020). Guia de acolhimento com classificação de risco e avaliação de vulnerabilidades para enfermeiros da atenção básica. Editora dos Editores. http://revista.farmacoterapia.pt/index.php/rpf/article/view/279.
Touret, F., & de Lamballerie, X. (2020). Of chloroquine and COVID-19. Antiviral research, 177, 104762. https://pubmed.ncbi.nlm.nih.gov/32147496/.
UNICEF. (2020). ORGANIZAÇÃO PAN-AMERICANA DA SAÚDE; ORGANIZAÇÃO MUNDIAL DA SAÚDE. Mensagens e ações importantes para a COVID-19 prevenção e controle em escolas. OPAS/BRA/Covid-19/20-015. Brazil. https://www.paho.org/bra/.
Yavuz, S., & Ünal, S. (2020). Antiviral treatment of COVID-19. Turkish journal of medical sciences, 50(SI-1), 611-619. https://pubmed.ncbi.nlm.nih.gov/32293834/.
Ying, W., Qian, Y., & Kun, Z. (2021). Drugs supply and pharmaceutical care management practices at a designated hospital during the COVID-19 epidemic. Research in Social and Administrative Pharmacy, 17(1), 1978-1983. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7136878/.
Zheng, Y. Y., Ma, Y. T., Zhang, J. Y., & Xie, X. (2020). COVID-19 and the cardiovascular system. Nature Reviews Cardiology, 17(5), 259-260. https://www.nature.com/articles/s41569-020-0360-5.
Zheng, S. Q., Yang, L., Zhou, P. X., Li, H. B., Liu, F., & Zhao, R. S. (2021). Recommendations and guidance for providing pharmaceutical care services during COVID-19 pandemic: a China perspective. Research in social and administrative pharmacy, 17(1), 1819-1824. https://pubmed.ncbi.nlm.nih.gov/32249102/.
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2021 Daniella Cavalcante da Silva; Carolinne de Oliveira Marquez; Nathana Costa Alves
This work is licensed under a Creative Commons Attribution 4.0 International License.
Authors who publish with this journal agree to the following terms:
1) Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution License that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal.
2) Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.
3) Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work.
